Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.

Snir O, Gomez-Cabrero D, Montes A, Perez-Pampin E, Gómez-Reino JJ, Seddighzadeh M, Klich KU, Israelsson L, Ding B, Catrina AI, Holmdahl R, Alfredsson L, Klareskog L, Tegnér J, Gonzalez A, Malmström V, Padyukov L.

Arthritis Res Ther. 2014 Aug 20;16(4):414. doi: 10.1186/s13075-014-0414-3.

2.

Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.

Snir O, Hesselberg E, Amoudruz P, Klareskog L, Zarea-Ganji I, Catrina AI, Padyukov L, Malmström V, Seddighzadeh M.

Genes Immun. 2013 Mar;14(2):83-9. doi: 10.1038/gene.2012.56. Epub 2012 Dec 20.

3.

Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations.

Seddighzadeh M, Gonzalez A, Ding B, Ferreiro-Iglesias A, Gomez-Reino JJ; Rheumatoid Arthritis Network and Coordinated Project, Klareskog L, Alfredsson L, Dunussi-Joannopoulos K, Clark JD, Padyukov L.

J Rheumatol. 2012 Aug;39(8):1509-16. doi: 10.3899/jrheum.111284. Epub 2012 Jul 1.

PMID:
22753649
4.

Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.

Ronninger M, Seddighzadeh M, Eike MC, Plant D, Daha NA, Skinningsrud B, Worthington J, Kvien TK, Toes RE, Lie BA, Alfredsson L, Padyukov L.

PLoS One. 2012;7(3):e32861. doi: 10.1371/journal.pone.0032861. Epub 2012 Mar 26.

5.

The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls.

Ronninger M, Guo Y, Shchetynsky K, Hill A, Khademi M, Olsson T, Reddy PS, Seddighzadeh M, Clark JD, Lin LL, O'Toole M, Padyukov L.

Genome Med. 2012 Jan 20;4(1):2. doi: 10.1186/gm301.

6.

Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis.

Dervieux T, Wessels JA, Kremer JM, Padyukov L, Seddighzadeh M, Saevarsdottir S, van Vollenhoven RF, Klareskog L, Huizinga TW, Guchelaar HJ.

Pharmacogenet Genomics. 2012 Jan;22(1):1-9. doi: 10.1097/FPC.0b013e32834d3e0b.

PMID:
22044941
7.

Preferential association of interferon regulatory factor 5 gene variants with seronegative rheumatoid arthritis in 2 Swedish case-control studies.

Wang C, Kokkonen H, Sandling JK, Johansson M, Seddighzadeh M, Padyukov L, Rantapää-Dahlqvist S, Syvänen AC.

J Rheumatol. 2011 Oct;38(10):2130-2. doi: 10.3899/jrheum.110322. Epub 2011 Aug 1.

8.

Ovarian cancer-associated polymorphisms in the BNC2 gene among women with endometriosis.

Sundqvist J, Falconer H, Seddighzadeh M, Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O, Gemzell-Danielsson K, D'Hooghe TM.

Hum Reprod. 2011 Aug;26(8):2253-7. doi: 10.1093/humrep/der169. Epub 2011 Jun 4.

PMID:
21642636
9.

Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.

Korotkova M, Daha NA, Seddighzadeh M, Ding B, Catrina AI, Lindblad S, Huizinga TW, Toes RE, Alfredsson L, Klareskog L, Jakobsson PJ, Padyukov L.

Eur J Hum Genet. 2011 Aug;19(8):908-14. doi: 10.1038/ejhg.2011.50. Epub 2011 Mar 30.

10.

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.

Padyukov L, Seielstad M, Ong RT, Ding B, Rönnelid J, Seddighzadeh M, Alfredsson L, Klareskog L; Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study group.

Ann Rheum Dis. 2011 Feb;70(2):259-65. doi: 10.1136/ard.2009.126821. Epub 2010 Dec 14.

11.

Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.

Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF; SWEFOT Trial Investigators Group.

Ann Rheum Dis. 2011 Mar;70(3):469-75. doi: 10.1136/ard.2010.139212. Epub 2010 Dec 13.

PMID:
21149498
12.
13.

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.

Vuong MT, Hahn-Zoric M, Lundberg S, Gunnarsson I, van Kooten C, Wramner L, Seddighzadeh M, Fernström A, Hanson LÅ, Do LT, Jacobson SH, Padyukov L.

Kidney Int. 2010 Dec;78(12):1281-7. doi: 10.1038/ki.2010.314. Epub 2010 Sep 1.

14.

Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1.

Sundqvist J, Falconer H, Seddighzadeh M, Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O, Padyukov L, Gemzell-Danielsson K, D'Hooghe TM.

Fertil Steril. 2011 Jan;95(1):437-40. doi: 10.1016/j.fertnstert.2010.07.1060. Epub 2010 Aug 24.

PMID:
20797713
15.

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.

Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M, Casemayou A, Lamouroux L, Duthoit C, Papapietro O, Sjöholm L, Bernard I, Lagrange D, Dahlman I, Lundmark F, Oturai AB, Soendergaard HB, Kemppinen A, Saarela J, Tienari PJ, Harbo HF, Spurkland A, Ramagopalan SV, Sadovnick DA, Ebers GC, Seddighzadeh M, Klareskog L, Alfredsson L, Padyukov L, Hillert J, Clanet M, Edan G, Fontaine B, Fournié GJ, Kockum I, Saoudi A, Olsson T.

Sci Transl Med. 2009 Dec 9;1(10):10ra21. doi: 10.1126/scitranslmed.3000278.

16.

Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome.

Grunewald J, Idali F, Kockum I, Seddighzadeh M, Nisell M, Eklund A, Padyukov L.

Tissue Antigens. 2010 Aug;76(2):96-101. doi: 10.1111/j.1399-0039.2010.01476.x. Epub 2010 Mar 10.

PMID:
20230522
17.

Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis.

D'Amato M, Zucchelli M, Seddighzadeh M, Anedda F, Lindblad S, Kere J, Alfredsson L, Klareskog L, Padyukov L.

PLoS One. 2010 Feb 22;5(2):e9315. doi: 10.1371/journal.pone.0009315.

18.

Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.

Seddighzadeh M, Korotkova M, Källberg H, Ding B, Daha N, Kurreeman FA, Toes RE, Huizinga TW, Catrina AI, Alfredsson L, Klareskog L, Padyukov L.

Eur J Hum Genet. 2010 Jul;18(7):821-6. doi: 10.1038/ejhg.2010.12. Epub 2010 Feb 24.

19.

Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.

Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sørensen PS, Lorentzen AR, Celius EG, Leppä V, Koivisto K, Tienari PJ, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, Olsson T.

Genes Immun. 2010 Mar;11(2):142-54. doi: 10.1038/gene.2009.82. Epub 2009 Oct 29.

PMID:
19865101
20.

Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy.

Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-Zoric M, Fernström A, Hanson LA, Do LT, Jacobson SH, Padyukov L.

Nephrol Dial Transplant. 2009 Oct;24(10):3061-7. doi: 10.1093/ndt/gfp079. Epub 2009 Mar 3.

21.

Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis.

Kling A, Seddighzadeh M, Arlestig L, Alfredsson L, Rantapää-Dahlqvist S, Padyukov L.

Ann Rheum Dis. 2008 Aug;67(8):1111-5. Epub 2007 Nov 15.

PMID:
18006541
22.

A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.

Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TW, Toes RE.

PLoS Med. 2007 Sep;4(9):e278. Erratum in: PLoS Med. 2007 Dec;4(12):e358.

23.

Association of arthritis with a gene complex encoding C-type lectin-like receptors.

Lorentzen JC, Flornes L, Eklöw C, Bäckdahl L, Ribbhammar U, Guo JP, Smolnikova M, Dissen E, Seddighzadeh M, Brookes AJ, Alfredsson L, Klareskog L, Padyukov L, Fossum S.

Arthritis Rheum. 2007 Aug;56(8):2620-32.

24.

Low IL-1alpha expression in bladder cancer tissue and survival.

Seddighzadeh M, Larsson P, Ulfgren AC, Onelöv E, Berggren P, Tribukait B, Torstensson A, Norming U, Wijkström H, Linder S, Steineck G.

Eur Urol. 2003 Apr;43(4):362-8.

PMID:
12667716
25.

Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms.

Seddighzadeh M, Steineck G, Larsson P, Wijkström H, Norming U, Onelöv E, Linder S.

Int J Cancer. 2002 Jun 10;99(5):721-6.

26.

Prognostic importance of the uPa/PAI-1 complex in breast cancer.

Sten-Linder M, Seddighzadeh M, Engel G, Rutqvist LE, Linder S, Skoog L, Wima B.

Anticancer Res. 2001 Jul-Aug;21(4B):2861-5.

PMID:
11712777
27.

Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma.

Seddighzadeh M, Steineck G, Jansson O, Larsson P, Wijkström H, Adolfsson J, Portwood N, Hansson J, Linder S.

Br J Cancer. 2001 Feb 2;84(3):329-34.

28.
29.

ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation.

Seddighzadeh M, Zhou JN, Kronenwett U, Shoshan MC, Auer G, Sten-Linder M, Wiman B, Linder S.

Clin Exp Metastasis. 1999;17(8):649-54.

PMID:
10919709

Supplemental Content

Loading ...
Support Center